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Abstract
Background: Bronchiectasis is deﬁned as an abnormal and irreversible dilation and distortion of
the bronchi, which has numerous causes. Surgical treatment of this disease is usually reserved
for focal disease and when the medical treatment is no longer effective. We report our center
experience and outcomes in bronchiectasis surgery during the last 20 years.
Methods: Between 1994 and 2014, sixty-nine patients underwent surgical resection for
bronchiectasis. Patient demographics, presenting symptoms, indications for surgical treatment,
type of lung resection, morbidity and mortality, as well as clinical follow-up and outcomes were
analyzed.
Results: From the 69 patients included, 31 (44.9%) were male and 38 (55.1%) were female.
Surgery was indicated because of unsuccessful medical therapy in 33 patients (47.8%), haemop-
tysis in 22 patients (31.9%), nondiagnostic lung mass in 9 patients (13.0%) and lung abscess in
5 patients (7.3%). The surgical procedures were lobectomy in 45 (65.2%) patients, pneumonec-
tomy in 10 (14.5%) patients, bilobectomy in 8 (11.6%) patients, lobectomy plus segmentectomy
in 3 (4.3%) patients and only segmentectomy in 3 (4.3%) patients. Morbidity rate was 14.5% and
there was no perioperative mortality. The follow-up was possible in 60 patients, with an out-
come reported as excellent in 44 (73.3%) patients, as improved in 11 (18.3%) and as unchanged
in 5 (8.3%).
Conclusion: Although the number of patients with bronchiectasis referred for surgical treatment
has decreased, pulmonary resection still plays a signiﬁcant role. Surgical resection of localized
bronchiectasis is a safe procedure with proven improvement of quality of life for the majority
of patients.
© 2015 Sociedade Portuguesa de Pneumologia. Published by Elsevier España, S.L.U. This
undis an open access article
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(31.9%), nondiagnostic lung mass in 9 patients (13.0%) and
lung abscess in 5 patients (7.3%). The surgical procedures
were lobectomy in 45 (65.2%) patients, pneumonectomy
in 10 (14.5%) patients, bilobectomy in 8 (11.6%) patients,
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Introduction
Bronchiectasis, originally described in 1819 by René
Laënnec,1 is a suppurative lung disease with heteroge-
neous phenotypic features. The characteristic features
consist of abnormal and irreversible dilation and distor-
tion of the bronchi, which has numerous causes. In the
pre-antibiotic era, it occurred frequently and it was an
important cause of morbidity and mortality.2,3 Nowadays,
there is a general belief that its incidence is falling due
to improvements in health care in recent decades, espe-
cially in developed countries, although recent literature
points out that the incidence of this pathology remains
largely unknown or underestimated.2--8 The incidence varies
widely (3.7--52/100,000 adults) between different studies,
probably due to methodology and diagnostic technology
availability differences.4,5 No recent population studies have
been carried out in Portugal.
Generally, the vast majority of patients can be managed
with conservative treatment, with surgical treatment being
reserved for focal disease and when medical treatment is no
longer effective. The concept behind surgical resection for
bronchiectasis is to remove permanently damaged areas of
the lung, with poor antibiotic penetration, and thus serve
as microbiological reservoir leading to recurrent infections.
Surgery for bronchiectasis currently still plays an impor-
tant role in thoracic surgical practice in several countries,
including Portugal.2,3 In order to evaluate the role of surgical
treatment of bronchiectasis in our center, we reviewed our
surgical experience and outcomes over the last 20 years.
Material and methods
Between January 1994 and July 2014, 69 patients with
bronchiectasis underwent pulmonary resection at cardio-
thoracic department of Centro Hospitalar de Vila Nova de
Gaia/Espinho. Preoperative assessment included their clini-
cal history, physical examination, lung function tests, chest
radiography and CT scan. Fiberoptic bronchoscopy was per-
formed in order to rule out any intraluminal pathology.
Evaluated parameters were patient demographics, pre-
senting symptoms, indications for surgical treatment, type
of lung resection, perioperative morbidity and mortality, as
well as clinical follow-up and outcomes.
Most patients were referred for surgery by their pul-
monologist after long term medical treatment; the ﬁnal
decision for surgery being reached at a weekly medico-
surgical meeting. Criteria for surgery included unsuccessful
medical therapy with recurrent respiratory infections, per-
sistent sputum production, chronic cough, persistent lung
abscess or haemoptysis and localized bronchiectasis. Before
surgery, all the patients underwent intensive respiratory
physiotherapy, microbiology exam of respiratory secretions
and antibiotic prophylaxis. A posterolateral thoracotomy
was performed in all patients under general anaesthetic
and orotracheal intubation with double lumen tube. Surgical
resection aimed at minimizing the number of resected seg-
ments without compromising the objective of elimination of
disease. Lobectomy was preferred if the disease was limited
to one lobe, pneumectomy if widespread and segmentec-
tomy when the disease did not affect the whole lobe or the
F
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ung function was mediocre. All resected specimens were
ubjected to histopathological examination to conﬁrm diag-
osis. Postoperative care included respiratory physiotherapy
nd antibiotic therapy. Perioperative mortality was deﬁned
s death within 30 days after surgery or during hospital stay.
lung function reevaluation was performed 6 months after
urgery to assess its effect on respiratory capacity.
Follow-up information was obtained during outpatient
linic visits or by telephone interview at least one year after
he surgery. The clinical outcome of surgery was assessed
y asking the patients to describe their current status with
espect to their preoperative status. This was classiﬁed
s: excellent, complete absence of preoperative symptoms;
mproved, a marked reduction in preoperative symptoms; or
nchanged, no improvement or worsening of preoperative
ymptoms.
Statistical analyses were carried out using Statistical
ackage for Social Sciences version 20. Functional results
ere compared using the paired t-test and/or Wilcoxon’s
ank test. A p value of less than 0.05 was considered signif-
cant.
esults
rom the 69 patients included in our study, 51 (73.9%) were
ubmitted to surgery during the ﬁrst decade of our study
1994--2004). In terms of gender distribution, 31 (44.9%)
atients were male and 38 (55.1%) patients were female.
ges ranged from 5 to 75 years, with a mean age of 38.6
ears. The majority of patients were aged over 30 years old
Fig. 1). Twelve (17.4%) patients had a smoking history and
ixteen (23.2%) had antecedents of pulmonary tuberculo-
is. Mean duration of symptoms was 4.5 year and included
ecurrent infections in 39 (56.5%) patients, persistent pro-
uctive cough in 33 (47.8%) patients, haemoptysis in 29 (42%)
atients and dyspnea on exertion in 11 (15.9%) patients.
ulmonary function tests were carried out before surgery:
(10.1%) patients had a restrictive defect and 3 (4.3%)
atients had an obstructive defect.
Surgery was indicated because of unsuccessful medical
herapy in 33 patients (47.8%), haemoptysis in 22 patients>6050-5940-4930-3920-2910-195-9
Age (years)
igure 1 Patient age distribution. 73.9% of patients were
ged over 30 years old.
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Table 1 Patient surgical procedures.
Procedure n (%)
Pneumonectomy
Left 4 (5.8)
Right 6 (8.7)
Lobectomy
Right upper lobe 9 (13.0)
Middle lobe 9 (13.0)
Right lower lobe 9 (13.0)
Left upper lobe 4 (5.8)
Left lower lobe 14 (20.3)
Bilobectomy
Superior (Right upper lobe +middle lobe) 3 (4.3)
Inferior (Right lower lobe +middle lobe) 5 (7.2)
Lobectomy + segmentectomy 3 (4.3)
Segmentectomy 3 (4.3)
Table 2 Spirometry values measured pre and postopera-
tively (in % of expected).
Preoperative Postoperative p value
FVC 86.15 ± 18.74 87.76 ± 15.21 0.169
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nFEV1 79.02 ± 20.32 78.29 ± 17.59 0.139
DLCO 74.513 ± 16.86 77.32 ± 26.77 0.109
obectomy plus segmentectomy in 3 (4.3%) patients and
nly segmentectomy in 3 (4.3%) patients. Complete oper-
tive details are given in Table 1. Median hospital stay
as 7 days (from 4 to 40 days). Morbidity rate was 14.5%.
he complications were: persistent air leak (>10 days) in
patients, rethoracotomy for haemorrhage in 2 patients,
ronchial stump dehiscence with bronchopleural ﬁstula,
osocomial pneumonia and atrial ﬁbrillation in 1 patient
ach. There was no perioperative mortality. The results of
ostoperative respiratory function reevaluation are shown
n Table 2. There were no signiﬁcant differences between
re and postoperative data.
Follow-up was possible in 60 (87%) patients. The clinical
utcome was reported as excellent in 44 (73.3%) patients,
s improved in 11 (18.3%) patients and as unchanged in
(8.3%) patients.
iscussion
his retrospective study observed 69 patients who under-
ent surgical treatment for bronchiectasis. Our results show
hat surgical management of bronchiectasis is highly effec-
ive in symptom-control and, therefore, in improving quality
f life in these patients. It represents a curative solu-
ion associated with low mortality and morbidity rates.
lthough there have not been any prospective randomized
rials comparing the short and long term efﬁcacy of sur-
ical and medical treatment,6,9 current literature clearly
tates that the primary therapeutic goal for bronchiectasis
atients must be optimal medical treatment.4--6 Appropriate
ntibiotic therapy, bronchodilators, and physiotherapy must
herefore be part of any form of bronchiectasis treatment.
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imilar to other series, the majority of our patients had had
ecurrent respiratory infections in the past, which empha-
izes the importance of appropriate medical treatment and
anagement of these infections.2,8,10
More than 70% of our patients were submitted to surgery
uring the ﬁrst decade of our two decade study period
1994--2004). This difference in the number of patients
ubmitted to surgical treatment between the two decades
ight be explained by the fact that it was believed that
he incidence of bronchiectasis within developed countries
opulations had decreased2--8 and then there was the
enewed interest in this pathology with the validation of new
tructured approaches to bronchiectasis medical treatment,
s recent publication of treatment reviews and management
uidelines may prove.4--7,11
Bronchiectasis was more common on the lower lobes.
t was thought that bronchiectasis would be more likely
o affect the left lung, due to anatomical features of the
eft main bronchus (smaller diameter and greater angu-
ation) that make it more prone to obstruction than the
ight one.2,6,10,12 However, as reported previously in a Por-
uguese study,2 we found a predominance of right lung
nvolvement (43 patients; 62.3%). This greater involvement
esulted mostly from a frequent partial or total involve-
ent of the middle lobe in 27 (62.8%) patients, which is
robably related to nonobstructive forms of middle lobe
yndrome.2,13,14
Bilateral resection was not performed on patients in our
tudy because of the numerous contraindications described
or this procedure.15 Pneumonectomy is reported to be a
igh-risk procedure especially for benign disease, but it
ay become necessary in rare cases of unilateral presen-
ation with one healthy lung.8,15,16 We have performed ten
neumonectomies with satisfactory results, especially for
atients with a destroyed lung. There was no mortality and
ne patient had a rethoracotomy for haemorrhage.
Overall perioperative morbidity ranges from 9.4% to
4.6% depending on the series6,16 and therefore our result
f 14.5% is acceptable. Bronchopleural ﬁstula occurred in
nly 1 patient due to a bronchial stump dehiscence after
right lower lobe lobectomy and was resolved with con-
ervative treatment. Although rare, the development of
ronchopleural ﬁstula is a source of signiﬁcant morbidity, so
t is important to avoid it whenever possible through adopt-
ng preventive measures, such as appropriate preoperative
ntimicrobial coverage, delaying surgery until there is no
pparent mucosal inﬂammation in preoperative bronchoﬁ-
roscopy and coverage of the stump during surgery.6,15,16
A normal pattern is usually found among pulmonary func-
ion tests of patients with bronchiectasis,2,3,8,17 although,
epending on the extent of lung damage, a functional
mpairment might be found in these patients.3,6,10 We have
ound functional impairment in less than one sixth of our
atients. Comparison between pre and postoperative func-
ion test values showed that surgery inﬂuenced neither
VC nor FEV1, despite parenchymal resection, which was as
xpected since the excised segments are diseased and do
ot contribute to pulmonary ventilation.2,3,8,17At follow-up, 55 (91.7%) patients were found to
ave improved their clinical condition. Only one patient
eported worsening in symptoms after surgery and four
atients showed no symptomatic improvement. This degree
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of symptomatic control is in line with the available
literature.2,3,6,10,12
Conclusion
Although the number of patients with bronchiectasis
referred to surgical treatment has decreased, pulmonary
resection still has a signiﬁcant role in this pathology. Surgical
resection of localized bronchiectasis is a safe procedure with
acceptable perioperative morbidity and mortality rates, and
proven improvement of quality of life among the majority
of patients.
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